ONC Insider Trading Activity and SEC Form 4 Filings
ONC insider trading summary
Over the past 12 months, insiders at BeOne Medicines Ltd. (ONC) reported 220 sales worth $377.4M by 17 insiders and no open-market purchases on SEC Form 4. Net insider selling was $377.4M.
Latest ONC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 27, 2026 | Xiaodong Wang | Director | Sell | $1.0M (2,841 @ $363.95) |
| Oct 27, 2026 | Xiaodong Wang | Director | Sell | $3.0M (8,148 @ $363.24) |
| Oct 27, 2026 | Xiaodong Wang | Director | Sell | $845K (2,331 @ $362.35) |
| Oct 27, 2026 | Xiaodong Wang | Director | Sell | $115K (320 @ $360.64) |
| Oct 27, 2026 | Xiaodong Wang | Director | Sell | $512K (1,440 @ $355.62) |
| Oct 27, 2026 | Xiaodong Wang | Director | Sell | $313K (880 @ $355.56) |
| Oct 27, 2026 | Xiaodong Wang | Director | Sell | $603K (1,681 @ $358.75) |
| Oct 27, 2026 | Xiaodong Wang | Director | Sell | $443K (1,239 @ $357.54) |
| Oct 27, 2026 | Xiaodong Wang | Director | Sell | $460K (1,280 @ $359.72) |
| Oct 27, 2026 | Xiaodong Wang | Director | Sell | $1.4M (3,965 @ $365.43) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.